D
West Pharmaceutical Services, Inc. WST
$263.51 -$15.59-5.59% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 131.80M 89.80M 130.10M 136.00M 111.30M
Total Depreciation and Amortization 41.40M 40.00M 40.70M 40.20M 38.90M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 8.00M -500.00K -4.20M 4.00M 700.00K
Change in Net Operating Assets -4.10M 100.00K 23.50M -100.00K 14.10M
Cash from Operations 177.10M 129.40M 190.10M 180.10M 165.00M
Capital Expenditure -75.20M -71.30M -104.90M -81.30M -100.20M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- 100.00K -800.00K -1.00M
Cash from Investing -75.20M -71.30M -104.80M -82.10M -101.20M
Total Debt Issued -- -- 0.00 129.70M 35.00M
Total Debt Repaid -300.00K -200.00K -100.00K -133.20M -58.30M
Issuance of Common Stock 5.20M 4.40M 3.10M 6.00M 6.80M
Repurchase of Common Stock -500.00K -136.00M -54.60M -52.40M -187.20M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -15.10M -15.20M -15.30M -14.50M -14.60M
Other Financing Activities -4.20M -- -2.00M -- --
Cash from Financing -14.90M -147.00M -68.90M -64.40M -218.30M
Foreign Exchange rate Adjustments 18.50M 8.50M -22.70M 11.10M -1.10M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 105.50M -80.40M -6.30M 44.70M -155.60M